Background illustration for clinical trials search

Glomerulonephritis Clinical Trials

Browse 135 glomerulonephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Transformative Research in Diabetic Nephropathy 2.0

for
Diabetic Nephropathies, Kidney Diseases,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07444203

Recruiting
Active & Responsive

Rutgers University Study of the Genetics of Kidney Disease

for
Kidney Disease, Kidney Disease, Chronic,
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT07217535

Recruiting
Active & Responsive

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

for
Abdominal Injury, Pelvic Fracture, Genital Hemorrhage,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 0+

Code: NCT04937868

Recruiting
Active & Responsive

Autonomic and Renal Contributions to Hypertension With ADT

for
Androgen Deprivation Therapy, Prostate Cancer, Hypertension,
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: Male

Age: 40+

Code: NCT07848828

Phase 4, Recruiting
Active & Responsive

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

for
Healthy, Lupus, Celiac, Kidney Disease, Chronic, Dermatologic
Location: Lexington MA
Sponsor: Joined Bio

Sex: All

Age: 18 - 70+

Code: NCT07128966

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase 3, Recruiting
Active & Responsive

Belimumab With Rituximab for Primary Membranous Nephropathy

for
Membranous Nephropathy, Nephrotic Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03949855

Phase 2, Recruiting
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Columbus OH, Lawrenceville GA, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting
Active & Responsive

Lupus Landmark Study: A Prospective Registry and Biorepository

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis,
Location: Boston MA, Worcester MA, Quebec, Manhasset NY,
Sponsor: Lupus Research Alliance

Sex: All

Age: 18 - 70+

Code: NCT05934149

Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: New Hyde Park NY, The Bronx NY, New York NY,
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting
Active & Responsive

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

for
Focal Segmental Glomerulosclerosis, Minimal Change Disease,
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 0+

Code: NCT05650619

Recruiting
Active & Responsive

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Location: New Hyde Park NY
Sponsor: iCell Gene Therapeutics

Sex: All

Age: 16 - 70

Code: NCT07328581

Phase 2, Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Fayetteville NC, Miami FL, Cooper City FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT07570862

Phase 2, Recruiting
Active & Responsive

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

for
IgA Nephropathy (IgAN)
Location: Jacksonville FL, Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06676579

Phase 2, Recruiting

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

for
Fibrillary Glomerulonephritis
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06295770

Phase 2, Recruiting

The Canadian Glomerulonephritis Registry and Translational Research Initiative

for
Glomerular Nephritis
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18 - 70+

Code: NCT03460054

Recruiting

Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures

for
Urologic Diseases, Male Urogenital Diseases, Urethral Stricture,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: Male

Age: 21 - 70+

Code: NCT03258658

Phase 1, Recruiting

Large Algorithm Setting and Validation Study

for
Bacterial Infections, Bacterial Infections and Mycoses,
Location: North Miami FL, New Orleans LA
Sponsor: Nanopath, Inc

Sex: Female

Age: 18+

Code: NCT07607470

Recruiting

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

for
Kidney Diseases, Kidney Failure, Chronic, Diabetic Nephropathy,
Location: New York NY
Sponsor: The Rogosin Institute

Sex: All

Age: 18+

Code: NCT01802034

Recruiting

Glomerulonephritis is inflammation of the glomeruli, the tiny filters inside the kidneys, and it can quietly cause protein and blood in the urine for years before kidney function declines. It includes several different diseases, such as IgA nephropathy, the most common worldwide, and FSGS, which often affects younger adults. For a long time treatment was limited to blood pressure medicines and broad immune suppression. Recent years brought the first targeted treatments for some forms, and many more are now being tested to protect kidney function before damage becomes permanent.